Cargando…

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents

Mutations in the COL7A1 gene lead to malfunction, reduction or complete absence of type VII collagen (C7) in the skin’s basement membrane zone (BMZ), impairing skin integrity. In epidermolysis bullosa (EB), more than 800 mutations in COL7A1 have been reported, leading to the dystrophic form of EB (D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liemberger, Bernadette, Bischof, Johannes, Ablinger, Michael, Hainzl, Stefan, Murauer, Eva M., Lackner, Nina, Ebner, Patricia, Kocher, Thomas, Nyström, Alexander, Wally, Verena, Mayr, Elisabeth, Guttmann-Gruber, Christina, Hofbauer, Josefina Piñón, Bauer, Johann W., Koller, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002491/ https://www.ncbi.nlm.nih.gov/pubmed/36901775 http://dx.doi.org/10.3390/ijms24054341

Ejemplares similares

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
por: Petković, Igor, et al.
Publicado: (2022)

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
por: Zauner, Roland, et al.
Publicado: (2023)

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022)

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
por: Kocher, Thomas, et al.
Publicado: (2017)

Trans-Splicing Improvement by the Combined Application of Antisense Strategies
por: Koller, Ulrich, et al.
Publicado: (2015)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations
por: Tockner, B, et al.
Publicado: (2016)

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies
por: Bornert, Olivier, et al.
Publicado: (2019)

A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020)

Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination
por: Kocher, Thomas, et al.
Publicado: (2019)

A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
por: Kocher, Thomas, et al.
Publicado: (2021)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

A novel screening system improves genetic correction by internal exon replacement
por: Koller, Ulrich, et al.
Publicado: (2011)

An ex vivo RNA trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
por: Peking, P., et al.
Publicado: (2018)

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017)

Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB
por: Georgiadis, Christos, et al.
Publicado: (2016)

Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair
por: Hüttner, Clemens, et al.
Publicado: (2016)

Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders
por: Koller, Ulrich, et al.
Publicado: (2014)

Signatures of Dermal Fibroblasts from RDEB Pediatric Patients
por: Beilin, Arkadii K., et al.
Publicado: (2021)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells
por: Mencía, Ángeles, et al.
Publicado: (2018)

Recessive dystrophic epidermolysis bullosa (RDEB) complicated by secondary hepatic amyloidosis
por: Chaptini, Cassandra, et al.
Publicado: (2015)

Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis
por: Brunner, Susanne M., et al.
Publicado: (2023)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
por: Eichstadt, Shaundra, et al.
Publicado: (2019)

372 HMGB1 Localization as a Driver of Carcinogenesis in RDEB-Associated Squamous Cell Carcinoma
por: Bui, Kacey Guenther, et al.
Publicado: (2023)

From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Corrigendum]
Publicado: (2021)

hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination
por: Evtushenko, Nadezhda A., et al.
Publicado: (2021)

Recessive dystrophic epidermolysis bullosa (RDEB): Oral manifestation and management rules in oral surgery: A case report
por: El Yacoubi, Oumayma, et al.
Publicado: (2022)

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
por: Bekric, Dino, et al.
Publicado: (2023)

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model
por: Kocher, T, et al.
Publicado: (2016)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

Epigenetic and metabolic regulation of epidermal homeostasis
por: Wagner, Roland N., et al.
Publicado: (2021)

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
por: Guttmann-Gruber, Christina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ck2urkg5308eg6n39dvfdm2gq